Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.50
-0.05 (-0.76%)
Apr 17, 2025, 4:29 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 6.82 million as of April 17, 2025. Its market cap has increased by 83.33% in one year.
Market Cap
6.82M
Enterprise Value
6.41M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.50
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 6.82M, a decrease of -75.01%. That is a compound annual growth rate of -17.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.17B |
| HUTCHMED (China) | 1.77B |
| Oxford Nanopore Technologies | 1.12B |